Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men

Clinical Pharmacology and Therapeutics

Volumn 59, Issue 1, 1996, Pages 72-82

  Goldberg, Michael R ^a   De Mey, Christian ^b   Wroblewski, Jill M ^b   Li, Qian ^b   Schroeter, Volkmar ^b   Beiz, Gustav G ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ENALAPRIL; LOSARTAN; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENALAPRIL; HAND; HUMANS; IMIDAZOLES; LOSARTAN; MALE; RECEPTORS, ANGIOTENSIN; REFERENCE VALUES; RENIN; TETRAZOLES; VASOCONSTRICTION; VEINS;

EID: 0030047004     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90026-0     Document Type: Article

References (18)

1. Smith RD, Chiu AT, Wong PC, Herblin WF, Timmermans P. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 1992;32:135-65.
2. Timmermans P, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens 1992;5(part 2);221S-35S.
3. Todd PA, Heel RC. Enalapril: a review of its pharmacodynamic and pharmaco-kinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1986;31:198-248.
4. Nelson E, Merrill D, Sweet C, et al. Efficacy and safety of oral MK-954 DuP 753, an angiotensin receptor antagonist, in essential hypertension. J Hypertension 1991;9(suppl 6):S468-9.
5. Weber MA. Clinical experience with the angiotensin II receptor antagonist losartan: a preliminary report. Am J Hypertens 1992;5(part 2):247S-51S.
6. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting-enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 1992;117:234-41.
7. Lindgren BR, Anderson RG. Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough: a research review. Med Toxicol Adverse Drug Exp 1989;4:369-80.
8. Cockcroft JR, Sciberras DG, Goldberg MR, Ritter JM. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J Cardiovasc Pharmacol 1993;22: 579-84.
9. Christen Y, Waeber B, Nussberger J, et al. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Circulation 1991;83:1333-42.
10. Goldberg M, Tanaka W, Barchowsky A, et al. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension 1993; 21:704-13.
11. Belz GG, Beermann C, Schloos J, Neugebauer G. Influence of carvedilol on the responsiveness of human hand veins to noradrenaline and dinoprost. Drugs 1988;36:(suppl 6)69-74.
12. Belz GG, Beermann C, Schloos J, Kleinbloesem CH. The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins. Br J Clin Pharmacol 1989;28:608-11.
13. Belz GG, Essig J, Wellstein A. Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril. J Cardiovasc Pharmacol 1987;9:219-24.
14. Munafo A, Christen Y, Nussberger J, et al. Drug concentration-response relationship in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. CLIN PHARMACOL THER 1992;51:513-21.
15. Mendenhall W, Scheaffer RL, Wackerly DD. Mathematical statistics with application. 3rd ed. Boston: PWS Publishers, 1986.
16. Milliken GA, Johnson DE. Analysis of messy data; vol I. New York: Van Nostrand Reinhold, 1984.
17. Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br J Clin Pharmacol 1993;35:290-7.
18. Arnold JMO, Lui AS, Thompson M. Does rapid development of tachyphylaxis to angiotensin II occur with local venous infusion? [Abstract]. Br J Clin Pharmacol 1992;34:443P.